BCNU

Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

Tebentafusp-tebn With LDT in Metastatic UM

Auto Stem Cell Transplant for Lymphoma Patients

Autologous Transplant in HIV Patients (BMT CTN 0803)

Therapeutic Targeting of Sex Differences in Pediatric Brain Tumor Glycolysis

Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT

Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies

R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma

Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease

Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma

Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies

UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy

Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma

Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease

Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL

Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma

Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma